EnzymeBioSystems | Income Statement

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
SG&A Expense
78.50
502.90
115.10
115.00
110.80
EBIT
78.50
502.90
178.40
125.40
110.80
Unusual Expense
-
-
-
-
10.00
Non Operating Income/Expense
-
-
-
-
25.00
Interest Expense
1.30
0.00
-
-
-
Pretax Income
79.80
502.90
178.40
125.40
95.80
Consolidated Net Income
79.80
502.90
178.40
125.40
95.80
Net Income
79.80
502.90
178.40
125.40
95.80
Net Income After Extraordinaries
79.80
502.90
178.40
125.40
95.80
Net Income Available to Common
79.80
502.90
178.40
125.40
95.80
EPS (Basic)
0.10
0.68
0.21
0.15
0.20
Basic Shares Outstanding
787.50
742.30
832.10
832.10
832.10
EPS (Diluted)
0.10
0.68
0.21
0.15
0.12
Diluted Shares Outstanding
787.50
742.30
832.10
832.10
832.10
EBITDA
78.50
502.90
178.40
125.40
110.80
Other Operating Expense
-
-
63.30
10.30
-

About EnzymeBioSystems

View Profile
Address
8440 West Lake Mead
Las Vegas Nevada 89128
United States
Employees -
Website http://enzymebiosystems.org
Updated 07/08/2019
EnzymeBioSystems engages in manufacturing specialty enzymes and enzyme related products. The company utilizes enzyme technologies to develop commercial solutions for applications within the specialty chemical industry. It plans to work collaboratively with industrial companies to develop differentiated enzyme solutions for target markets.